Last update:

Allergy and immunology news

Pilot trial suggests anti-inflammatory drug could help difficult-to-treat depression

Immunotherapy could be a promising new treatment option for patients with difficult-to-treat depression. This is a key finding from a University of Bristol-led pilot randomized controlled clinical trial, published in JAMA ...

How dead tumor cells could make chemotherapy and radiotherapy work better

As tumors outgrow their blood and nutrient supplies, or respond to treatments like chemotherapy and radiotherapy, individual cancer cells die, exposing their internal scaffolds. These dead cells are an abundant source of ...

Researchers discover new clues to delaying type 1 diabetes

Thomas Delong, Ph.D., moved to Colorado from Germany two decades ago intent on one thing: understanding the origin of type 1 diabetes (T1D) and finding ways to stop it. Diagnosed at age 12 with the disease that affects 9.5 ...

Lab-designed molecule offers hope for celiac disease sufferers

A research project led by the Institute for Research in Nutrition and Food Safety (INSA) and the Faculty of Pharmacy and Food Sciences at the University of Barcelona, together with the Molecular Biology Institute of Barcelona ...

Immune system overreaction linked to deadly flu in pregnancy

In most people, influenza stays in the upper respiratory tract—mainly the nose—and clears without spreading further. But during pregnancy, the virus can extend beyond the lungs into the cardiovascular system, increasing the ...